Cucurbitacin IIA
CAS: 58546-34-2
Ref. TM-T3S1471
1mg | 35.00 € | ||
5mg | 69.00 € | ||
10mg | 109.00 € | ||
25mg | 198.00 € | ||
50mg | 297.00 € | ||
100mg | 441.00 € | ||
500mg | 917.00 € |
Product Information
- Dihydrocucurbitacin Q1, Hemslecin A, Curcurbitacin IIA
- (2β,3α,9β,10α,16α)-25-(Acetyloxy)-2,3,16,20-tetrahydroxy-9-methyl-19-norlanost-5-ene-11,22-dione
- 19-Norlanost-5-ene-11,22-dione, 25-(acetyloxy)-2,3,16,20-tetrahydroxy-9-methyl-, (2beta,3alpha,9beta,10alpha,16alpha)-
- 19-Norlanost-5-ene-11,22-dione, 25-(acetyloxy)-2,3,16,20-tetrahydroxy-9-methyl-, (2β,3α,9β,10α,16α)-
- 23,24-Dihydrocucurbitacin F 25-acetate
- 23,24-Dihydrocucurbitacin F-25-O-acetate
- 25-Acetoxy-23,24-dihydrocucurbitacin F
- 25-O-Acetyl-23,24-dihydrocucurbitacin F
- Cucurbitacin II<sub>a</sub>
- Dihydrocucurbitacin F 25-O-acetate
- See more synonyms
- Dihydrocucurbitacin Q1
- Hemslecin A
- estr-5-en-11-one, 17-[(1R)-5-(acetyloxy)-1-hydroxy-1,5-dimethyl-2-oxohexyl]-2,3,16-trihydroxy-4,4,9,14-tetramethyl-, (2beta,3alpha,9beta,10alpha,16alpha,17beta)-
1. Cucurbitacin IIA (Dihydrocucurbitacin Q1) can induce apoptosis and enhance autophagy , contributes to the anti-inflammatory activity of Cucurbitacin IIA against inflammation-related diseases. 2. Cucurbitacin IIA is a novel class of anti-cancer drug in suppression of cancer cell expansion by disrupting the actin cytoskeleton and directing the cell to undergo PARP-mediated apoptosis through the inhibition of survivin downstream of JAK2/STAT3.
Chemical properties
Technical inquiry about: TM-T3S1471 Cucurbitacin IIA
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.